[Antipsychotics--clever choices]

Lakartidningen. 2007 Feb;104(7):504-8.
[Article in Swedish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antipsychotic Agents* / adverse effects
  • Antipsychotic Agents* / economics
  • Antipsychotic Agents* / therapeutic use
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use
  • Clinical Trials as Topic
  • Clozapine / adverse effects
  • Clozapine / therapeutic use
  • Drug Costs
  • Evidence-Based Medicine
  • Glucose Intolerance / chemically induced
  • Haloperidol / adverse effects
  • Haloperidol / therapeutic use
  • Humans
  • Lipids / blood
  • Olanzapine
  • Perphenazine / adverse effects
  • Perphenazine / therapeutic use
  • Practice Guidelines as Topic
  • Risk Factors
  • Risperidone / adverse effects
  • Risperidone / therapeutic use
  • Schizophrenia / drug therapy
  • Selective Serotonin Reuptake Inhibitors* / adverse effects
  • Selective Serotonin Reuptake Inhibitors* / economics
  • Selective Serotonin Reuptake Inhibitors* / therapeutic use
  • Weight Gain / drug effects

Substances

  • Antipsychotic Agents
  • Lipids
  • Serotonin Uptake Inhibitors
  • Benzodiazepines
  • Perphenazine
  • Clozapine
  • Haloperidol
  • Risperidone
  • Olanzapine